The unloved legal eagles chalking up bumper returns
In a year in which 'quality growth' stocks stretched their outperformance over 'value' stocks, notwithstanding a late bounce-back in the latter on the announcement of a Covid vaccine, it seems odd that UK investors should have...
04 February 2021